Suanfarma Biotech
Suanfarma Biotech engages in the development, manufacture, and distribution of raw materials and finished dosage forms for pharmaceutical, biotechnological, veterinary, nutritional, and cosmetic sectors. It offers generics and active pharmaceutical ingredients, such as anti-infective, cardiovascular system, central nervous system, digestive system, endocrine system, oncology, respiratory system, and pain and inflammation products; and food supplements, and medicinal and dietary plants, including non-native vegetable species, dietary supplements, plant extracts, jellies, syrups, oligotherapy, litotherapy, etc. Suanfarma Biotech also provides active ingredients for veterinary industry, such as antibiotics, NSAIDs, antiparasitics, glucocorticoids, nutritional, reproduction, and others; and develops alternative routes of synthesis for obtaining active pharmaceutical ingredients and their subsequent industrial scale-up. In addition, it invests in seed and early-stage biotechnology companies; delivers its expertise to biotech companies on issues related to business and commercial management; and provides support on scientific, industrial, regulatory, and financial development. Suanfarma Biotech serves customers in Spain and internationally. It began operation in 1993, with its headquarters in Alcobendas in Spain and locations in Phoenix in Arizona, Fair Lawn in New Jersey, Naucalpan de Juárez in Mexico; Bogotá in Colombia, Caracas in Venezuela, Sao Paulo in Brazil, Buenos Aires in Argentina, Santiago in Chile, Madrid and Barcelona in Spain, Fitbourg in Switzerland, Dubai in the United Arab Emirates, Navi Mumbai in India, and Shanghai in China.
Cipan specializes in the research, development and production of active pharmaceutical ingredients, primarily anti-infection agents.
Idifarma Desarrollo Farmacéutico
Venture Round in 2016
Idifarma Desarrollo Farmacéutico, S.L., founded in 2001 and based in Noain, Spain, specializes in contract development and manufacturing services for the pharmaceutical and biotechnological sectors. The company offers a comprehensive range of services that encompass the entire lifecycle of pharmaceutical products, including active pharmaceutical ingredient (API) selection, formulation development, GMP manufacturing, quality control, and regulatory affairs. Idifarma also provides packaging services for both investigational and commercial medicinal products. Serving over 100 international clients, from start-ups to large multinationals, Idifarma is equipped to handle both generic medications and innovative drug formulations. With a commitment to quality and efficiency, the company implements a strict quality control system and utilizes high-performance equipment to deliver tailored solutions within established deadlines.
PEVESA
Venture Round in 2013
PEVESA is a biotechnology company that specializes in the development and manufacturing of nutritional food ingredients and protein derivatives. The company focuses on utilizing proteins to create isolates, hydrolysates, peptides, and amino acids, employing biological catalysts such as enzymes in its processes. PEVESA's strength lies in its ability to develop custom products tailored to the specific needs of its clients. The company aims to establish itself as a leader in customized production across various sectors, including food, nutraceuticals, fermentation media, cosmetics, and bio-agriculture. Through its innovative approach, PEVESA seeks to provide healthy food options and supplements for consumers.
3P Biopharmaceuticals
Venture Round in 2008
3P Biopharmaceuticals is a contract manufacturing firm specializing in the biotechnology sector, focusing on the production of biologics and cell therapy products. The company develops recombinant proteins for both therapeutic and diagnostic applications and provides a range of products, including monoclonal antibodies, interleukins, vaccines, and biosimilars. By enabling clients to access safe and advanced medicines, 3P Biopharmaceuticals plays a significant role in enhancing health and well-being. Its contributions are vital in addressing contemporary challenges in healthcare, agriculture, and environmental sustainability, positioning the company as a key player in the evolving landscape of biotechnology.
Digna Biotech
Venture Round in 2007
Digna Biotech specializes in the development of therapeutic and diagnostic products aimed at addressing acute hospital cases. The company utilizes advanced scientific and clinical expertise to transform early-stage medical innovations into clinical-stage candidates suitable for further development and commercialization. In addition to their core offerings, Digna Biotech provides clinical development and commercial launch services, alongside a range of pharmaceutical products, to support healthcare advancements and improve patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.